Latvia - Renin-Angiotensin System Medicine Use
Since 2014, Latvia Renin-Angiotensin System Medicine Use decreased by 2.3% year on year. In 2019, the country was ranked number 27 among other countries in Renin-Angiotensin System Medicine Use at 71.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia is overtaken by Turkey, which was ranked number 26 with 87.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by South Korea at 46.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +0.6% compared to 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +10.2% per year, while Chile recorded the worst performance at -3.5% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 71.20 |
| 2018 | 71.00 |
| 2017 | 74.20 |
| 2016 | 74.60 |
| 2015 | 77.30 |
How does Latvia rank in Renin-Angiotensin System Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
| 2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
| 26 |
#26
Turkey
|
88 | 2019 | +0.5 % | +3.1 % | View data | |
| 27 |
#27
Latvia
|
71 | 2019 | +0.3 % | -2.3 % | View data | |
| 28 |
#28
South Korea
|
46 | 2019 | +0.0 % | +0.3 % | View data | |